Article
Neurosciences
Alyssa N. Coyne, Jeffrey D. Rothstein
Summary: Nuclear pore complex injury plays a significant role in ALS pathogenesis, with aberrant nuclear accumulation of the ESCRT-III protein CHMP7 being a key pathological event. While VPS4 expression is increased in ALS neuronal nuclei, CHMP4B and CHMP2B levels do not show a similar increase. Therapeutic efforts to mitigate this pathogenic cascade should focus on upstream events such as the nuclear accumulation of CHMP7.
ACTA NEUROPATHOLOGICA COMMUNICATIONS
(2021)
Article
Cell Biology
Hyun Sung, Thomas E. Lloyd
Summary: Macroautophagy is crucial for eliminating protein aggregates and damaged organelles, and its dysregulation is implicated in neurodegenerative diseases like ALS and FTD. The expansion of G4C2 repeats in the C9orf72 gene disrupts autophagosome formation, highlighting the importance of dynamic ER tubules.
Article
Cell Biology
Hyun Sung, Thomas E. Lloyd
Summary: Expression of expanded G(4)C(2) repeats differentially affects axonal transport of vesicular organelles and mitochondria in Drosophila models.
Article
Cell Biology
Zulin Wu, Haiqian Xu, Junze Liu, Fan Zhou, Yongheng Liang
Summary: The study reveals that the ESCRT-III complex in yeast plays a role in mediating macromitophagy induced by nitrogen starvation. By interacting with components of the autophagosome and mitophagy receptor, the ESCRT-III complex contributes to the delivery and degradation of mitochondria. The results suggest a new function for ESCRT-III in regulating mitochondrial clearance in yeast.
Article
Cell Biology
Yong-Woo Jun, Soojin Lee, Byung-Kwan Ban, Jin-A Lee, Fen-Biao Gao
Summary: Partial knockdown of MYH10 rescues neurodegeneration in both Drosophila and human iPSC-derived cortical neurons expressing mutant CHMP2B, and MYH10 interacts with ESCRT-III to regulate phagophore closure during mitophagy, revealing novel roles of MYH10 in the autophagy pathway and in ESCRT-related FTD pathogenesis.
Article
Biochemistry & Molecular Biology
Yu Li, Ji Geng, Suman Rimal, Haochuan Wang, Xiangguo Liu, Bingwei Lu, Shuangxi Li
Summary: This study demonstrates that mTORC2/AKT signaling is activated by APP, TDP-43 and FUS, and that mTORC2/AKT and its downstream target valosin-containing protein mediate the effect of these proteins on the quality control of C9-ALS/FTD-associated poly(GR) translation. The findings also suggest that mTORC2/AKT signaling and GCN2/eIF2 alpha integrated stress response are common signaling pathways underlying ALS/FTD pathogenesis.
JOURNAL OF BIOLOGICAL CHEMISTRY
(2023)
Article
Clinical Neurology
Pedro Ervilha Pereira, Nika Schuermans, Antoon Meylemans, Pontus LeBlanc, Lauren Versluys, Katie E. E. Copley, Jack D. D. Rubien, Christopher Altheimer, Myra Peetermans, Elke Debackere, Olivier Vanakker, Sandra Janssens, Jonathan Baets, Kristof Verhoeven, Martin Lammens, Sofie Symoens, Boel De Paepe, Sami J. J. Barmada, James Shorter, Jan L. L. De Bleecker, Elke Bogaert, Bart Dermaut
Summary: This study identified a TDP-43(p.Trp385IlefsTer10) mutation in a family, which led to the presence of TDP-43-positive inclusions in muscle cells and the development of autosomal dominant rimmed vacuole myopathy. The mutation was found to increase the aggregation propensity of TDP-43, but it was not associated with ALS and FTD.
ACTA NEUROPATHOLOGICA
(2023)
Article
Biology
Madeleine R. R. Chalmers, JiHye Kim, Nam Chul Kim
Summary: The study found that miR-34 and Eip74EF have different effects on age-related diseases in Drosophila. It was demonstrated that inhibiting the expression of Eip74EF is beneficial to the Spinocerebellar ataxia type 3 model, while the overexpression of miR-34 has toxic effects on the Drosophila eye disease model.
BMC RESEARCH NOTES
(2023)
Article
Rheumatology
Iago Pinal-Fernandez, Maria Casal-Dominguez, John A. Carrino, Arash H. Lahouti, Pari Basharat, Jemima Albayda, Julie J. Paik, Shivani Ahlawat, Sonye K. Danoff, Thomas E. Lloyd, Andrew L. Mammen, Lisa Christopher-Stine
ANNALS OF THE RHEUMATIC DISEASES
(2017)
Article
Neurosciences
Yun Ha Jeong, Jonathan P. Ling, Sophie Z. Lin, Aneesh N. Donde, Kerstin E. Braunstein, Elisa Majounie, Bryan J. Traynor, Katherine D. LaClair, Thomas E. Lloyd, Philip C. Wong
MOLECULAR NEURODEGENERATION
(2017)
Article
Clinical Neurology
Thomas E. Lloyd, Iago Pinal-Fernandez, E. Harlan Michelle, Lisa Christopher-Stine, Katherine Pak, Ned Sacktor, Andrew L. Mammen
Article
Developmental Biology
Yunzi Gou, Jinbai Guo, Kirstin Maulding, Bruce B. Riley
DEVELOPMENTAL BIOLOGY
(2018)
Review
Clinical Neurology
Sarah H. Berth, Thomas E. Lloyd
CURRENT TREATMENT OPTIONS IN NEUROLOGY
(2020)
Article
Biology
Kathleen M. Cunningham, Kirstin Maulding, Kai Ruan, Mumine Senturk, Jonathan C. Grima, Hyun Sung, Zhongyuan Zuo, Helen Song, Junli Gao, Sandeep Dubey, Jeffrey D. Rothstein, Ke Zhang, Hugo J. Bellen, Thomas E. Lloyd
Article
Multidisciplinary Sciences
Brett A. McCray, Erika Diehl, Jeremy M. Sullivan, William H. Aisenberg, Nicholas W. Zaccor, Alexander R. Lau, Dominick J. Rich, Benedikt Goretzki, Ute A. Hellmich, Thomas E. Lloyd, Charlotte J. Sumner
Summary: TRPV4 interacts with RhoA, affecting cell structure. The neuropathy effects of TRPV4 are related to incorrect binding with RhoA. Inhibition of RhoA can restore neurite length.
NATURE COMMUNICATIONS
(2021)
Article
Cell Biology
Benjamin L. Zaepfel, Zhe Zhang, Kirstin Maulding, Alyssa N. Coyne, Weiwei Cheng, Lindsey R. Hayes, Thomas E. Lloyd, Shuying Sun, Jeffrey D. Rothstein
Summary: The study found that overexpression of UPF1 protein can mitigate neurotoxicity in C9orf72 ALS/FTD models by reducing the severity of known neurodegenerative phenotypes without affecting NMD function itself.
Article
Clinical Neurology
Christopher Grunseich, Nathan Sarkar, Joyce Lu, Mallory Owen, Alice Schindler, Peter A. Calabresi, Charlotte J. Sumner, Ricardo H. Roda, Vinay Chaudhry, Thomas E. Lloyd, Thomas O. Crawford, S. H. Subramony, Shin J. Oh, Perry Richardson, Kurenai Tanji, Justin Y. Kwan, Kenneth H. Fischbeck, Ami Mankodi
Summary: Integrating deep phenotyping, gene filter algorithms, and biological assays increased the diagnostic yield of exome sequencing, identified novel pathogenic variants, and extended the phenotypes of difficult-to-diagnose rare neurogenetic disorders in an outpatient clinic setting.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
(2021)
Article
Cell Biology
Hyun Sung, Thomas E. Lloyd
Summary: Expression of expanded G(4)C(2) repeats differentially affects axonal transport of vesicular organelles and mitochondria in Drosophila models.
Article
Cell Biology
Hyun Sung, Thomas E. Lloyd
Summary: Macroautophagy is crucial for eliminating protein aggregates and damaged organelles, and its dysregulation is implicated in neurodegenerative diseases like ALS and FTD. The expansion of G4C2 repeats in the C9orf72 gene disrupts autophagosome formation, highlighting the importance of dynamic ER tubules.
Review
Medicine, Research & Experimental
Sarah H. Berth, Thomas E. Lloyd
Summary: Neurons heavily depend on axonal transport for their health due to their compartmentalization. Axonal transport is essential for delivering newly synthesized macromolecules and organelles from the cell body to the synapse (anterograde transport) and for the retrograde delivery of signaling endosomes and autophagosomes for degradation. Dysfunction in axonal transport is an early event in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, hereditary spastic paraplegia, amyotrophic lateral sclerosis, and Charcot-Marie-Tooth disease. This article provides an overview of the mechanisms regulating axonal transport, discusses their disruption in various neurodegenerative diseases, and explores therapeutic approaches targeting axonal transport.
JOURNAL OF CLINICAL INVESTIGATION
(2023)
Article
Clinical Neurology
Anne-Katrin Guettsches, Stefen Brady, Kathryn Krause, Alexandra Maerkens, Julian Uszkoreit, Martin Eisenacher, Anja Schreiner, Sara Galozzi, Janine Mertens-Rill, Martin Tegenthoff, Janice L. Holton, Matthew B. Harms, Thomas E. Lloyd, Matthias Vorgerd, Conrad C. Weihl, Katrin Marcus, Rudolf A. Kley
ANNALS OF NEUROLOGY
(2017)